This reengineered HPV vaccine trains T cells to hunt down cancer

3 weeks ago 28
ARTICLE AD BOX

Over the last decade, scientists at Northwestern University have identified a key insight about how vaccines work. The ingredients matter, but the way those ingredients are physically arranged can dramatically influence performance.

After validating this concept in multiple studies, the researchers applied it to therapeutic cancer vaccines aimed at HPV-driven tumors. In their latest work, they found that simply adjusting the orientation and position of a singl...

Read Entire Article